Skip to content

Validation of the 3D-CAM to Detect Postoperative Delirium

Validation of the 3D-CAM in the Recovery Room to Detect Postoperative Delirium Compared to Nu-DESC, CAM and DSM-5 Criteria

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02992717
Enrollment
200
Registered
2016-12-14
Start date
2017-01-09
Completion date
2018-01-05
Last updated
2018-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Delirium

Brief summary

The 3D-CAM is a new 3-minute diagnostic assessment for Confusion Assessment Method-defined Delirium. The primary objective of this study is to translate the 3D-CAM into the German language, as well as to validate its use to detect postoperative delirium in the recovery room. The validation will be based on comparisons to the Nu-DESC (Nursing Delirium Screening Scale), CAM (Confusion Assessment Method), and DSM-5 criteria (Diagnostic and Statistical Manual of Mental Disorders).

Detailed description

Approximately 200 patients will be enrolled in the study. They will followed up until the third postoperative day. Calculation and analysis of demographic and perioperative influencing factors on postoperative delirium according to routine parameters (age, sex, body height, body weight, diagnosis, physical status according to the American Society of Anaesthesiologists (ASA PS), duration of surgery, Physiological and Operative Severity Score (POSSUM), type of anesthesia, medication against pain and delirium) will be performed.

Interventions

None listed

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male and female patients with age ≥ 18 years * Admission to recovery room (RR) or post anaesthesia care unit (PACU) following elective general anaesthesia and scheduled * Inpatient treatment not less than 24 hours.

Exclusion criteria

* Patients with psychiatric diseases and mental retardation * Analphabetism * Anacusis or Hypoacusis with hearing aid device, * Amaurosis * Lacking willingness to save and hand out data within the study * Accommodation in an institution due to an official or judicial order * Patients with unability speaking German or English language * Participation in other clinical studies during the study period * Coworker in the study site

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity of the delirium screening/diagnosing tool 3D Confusion Assessment Method (3D-CAM)Up to three daysSensitivity of the delirium screening/diagnosing tool 3D Confusion Assessment Method (3D-CAM) to detect postoperative delirium (POD) in the recovery room - Used reference standard: DSM-5 criteria
Specificity of the delirium screening/diagnosing tool 3D Confusion Assessment Method (3D-CAM)Up to three daysSpecificity of the delirium screening/diagnosing tool 3D Confusion Assessment Method (3D-CAM) to detect postoperative delirium (POD) in the recovery room - Used reference standard: DSM-5 criteria

Secondary

MeasureTime frameDescription
Duration of stay in recovery roomUp to three days
Duration of performance of the delirium testingsUp to three days
Pain levelParticipants will be followed up until the third postoperative day
Test Quality LevelUp to three daysComparison of test Quality level between 3D-CAM, Nu-DESC and CAM to detect POD in the recovery room.
Duration of hospital stayParticipants will be followed for the duration of hospital stay an expected average of 3 weeks
In-house mortalityParticipants will be followed for the duration of hospital stay an expected average of 3 weeks
Follow-up careParticipants will be followed for the duration of hospital stay an expected average of 3 weeks
Postoperative complicationsUp to three daysPostoperative complications according to Clavien-Dindo classification
Duration of postoperative deliriumUp to three days

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026